Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
{{output}}
Introduction: Atypical hemolytic uremic syndrome (aHUS) is a potentially life-threatening condition associated with poor clinical outcomes if not treated adequately. Eculizumab has become the standard of care, whereas ravulizumab... ...
